THYROID CARCINOMA
Clinical trials for THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: THYROID CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Drug safety watch for advanced thyroid cancer treatment
Disease control OngoingThis study is monitoring the safety and long-term effectiveness of the drug sorafenib (NEXAVAR®) in patients with advanced thyroid cancer that cannot be removed by surgery. It will follow 453 patients in Japan for up to two years to track side effects and survival rates. The goal…
Matched conditions: THYROID CARCINOMA
Sponsor: Bayer • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC